Novavax, Inc.
NVAX
Market Cap$1.04B
Close$
$24.78
281.3% upside
Current Fair Value
281.3% upsideUndervalued by 281.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.04 Billion |
|---|---|
| Enterprise Value | $1.15 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.23 |
| Beta | 2.77 |
| Outstanding Shares | 161,049,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 2.16 |
|---|---|
| PEG | -0.48 |
| Price to Sales | 0.93 |
| Price to Book Ratio | -6.5 |
| Enterprise Value to Revenue | 0.91 |
| Enterprise Value to EBIT | 2.41 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | 0.32 |
| Debt to Equity | -4.91 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Novavax, Inc.
CEO: Stanley Erck